## Abstract ## Purpose To develop a new method of measuring quantitative regional cerebral blood volume (CBV) using epochs of hyperoxia as an intravenous contrast agent with T2\*‐weighted MRI. ## Materials and Methods Images were acquired from six subjects (four male, two female, mean age 29 ± 3
Quantitative measurement of spinal cord blood volume in humans using vascular-space-occupancy MRI
✍ Scribed by Hanzhang Lu; Meng Law; Yulin Ge; Stephen M. Hesseltine; Otto Rapalino; Jens H. Jensen; Joseph A. Helpern
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 174 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0952-3480
- DOI
- 10.1002/nbm.1185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Although perfusion is of major interest for many spinal cord disorders, there is no established, reproducible technique for evaluating blood flow or blood volume of the spinal cord in humans. Here the first report of in vivo measurement of human spinal cord blood volume (scBV) is presented. An FDA‐approved contrast agent, Gd‐DTPA, was used as an intravascular agent for the cord parenchyma, and pre‐/post‐contrast vascular‐space‐occupancy (VASO) MRI experiments were performed to obtain a quantitative estimation of scBV in mL blood/100 mL tissue. VASO MRI was used because it does not rely on knowledge of an arterial input function, it avoids the imaging artifacts of single‐shot echo planar imaging approaches, and it requires only relatively simple and direct calculations for scBV quantification. Preliminary tests at 1.5 T and 3 T gave mean ± SD scBV values of 4.3 ± 0.7 ml/100 mL tissue (n = 6) and 4.4 ± 0.7 ml/100 mL tissue (n = 4), respectively, consistent with the expectation that the scBV values would not be field‐dependent. Copyright © 2007 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract Quantitative determination of cerebral blood volume (CBV) is important for understanding brain physiology and pathophysiology. In this work, a novel approach is presented for accurate measurement of absolute CBV (aCBV) using vascular‐space‐occupancy (VASO) MRI, a blood‐nulling pulse seq
## Abstract Breakdown of the blood‐brain barrier (BBB), occurring in many neurological diseases, has been difficult to measure noninvasively in humans. Dynamic contrast‐enhanced magnetic resonance imaging measures BBB permeability. However, important technical challenges remain and normative data f